ESC 365 - MicroRNAs and fibrosis, pathophysiological role and possible therapy.

ESC Premium Access

MicroRNAs and fibrosis, pathophysiological role and possible therapy.

Session: Cardiac fibrosis quo vadis?

Topic: Hypertrophy, cell cycle and apoptosis

Speaker: Professor T. Thum (Hannover, DE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

27 presentations

1 follower

3 more presentations in this session

Pathophysiology and the clinical consequences of myocardial fibrosis.

Speaker: Professor R. De Boer (Rotterdam, NL)

Evaluation of myocardial fibrosis. Are imaging techniques ready for prime time?

Speaker: Professor T. Marwick (Melbourne, AU)

Pharmacological therapies for myocardial fibrosis.

Speaker: Professor F. Jaisser (Paris, FR)

Access the full session

Cardiac fibrosis quo vadis?

Speakers: Professor T. Thum, Professor R. De Boer, Professor T. Marwick, Professor F. Jaisser

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources